BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pizzoferrato M, Puca P, Ennas S, Cammarota G, Guidi L. Glucagon-like peptide-2 analogues for Crohn’s disease patients with short bowel syndrome and intestinal failure. World J Gastroenterol 2022; 28(44): 6258-6270 [PMID: 36504557 DOI: 10.3748/wjg.v28.i44.6258]
URL: https://www.wjgnet.com/1007-9327/full/v28/i44/6258.htm
Number Citing Articles
1
Roger Atanga, Varsha Singh, Julie G. In. Intestinal Enteroendocrine Cells: Present and Future Druggable TargetsInternational Journal of Molecular Sciences 2023; 24(10): 8836 doi: 10.3390/ijms24108836
2
Shinichiro Shinzaki, Toshiyuki Sato, Hirokazu Fukui. Antidiabetic drugs for IBD: a long but promising road ahead for drug repositioning to target intestinal inflammationJournal of Gastroenterology 2023; 58(6): 598 doi: 10.1007/s00535-023-01983-y
3
Rafaela de Assis Neves, Maria Carolina Gonçalves Dias, Tatiana Palotta Minari, Mariana Martins da Rocha Hollanda, André Dong Won Lee, Dan Linetzky Waitzberg. Translation into Brazilian Portuguese and transcultural adaptation and validation of the treatment specific questionnaire Home Parenteral Nutrition- Quality of Life (HPN-QOL©)Clinical Nutrition ESPEN 2024; 61: 338 doi: 10.1016/j.clnesp.2024.04.004
4
Thorir G. Pálsson, Hannah Gilliam-Vigh, Benjamin A.H. Jensen, Palle B. Jeppesen, Asger B. Lund, Filip K. Knop, Casper K. Nielsen. Targeting the GLP-2 receptor in the management of obesityPeptides 2024; 177: 171210 doi: 10.1016/j.peptides.2024.171210
5
Sarina Gadgaard, Johanne A. Windeløv, Sine P. Schiellerup, Jens J. Holst, Bolette Hartmann, Mette M. Rosenkilde. Long-acting agonists of human and rodent GLP-2 receptors for studies of the physiology and pharmacological potential of the GLP-2 systemBiomedicine & Pharmacotherapy 2023; 160: 114383 doi: 10.1016/j.biopha.2023.114383